---
schema_version: "secwatch.filing_event.v1"
accession: "0001739104-25-000068"
form_type: "8-K"
ticker: "ELAN"
cik: "0001739104"
company_name: "Elanco Animal Health Inc"
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:20:43.612427+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Elanco Q3 revenue $1.14B (+10% YoY); raises FY guidance, net leverage improves

## Summary
- Q3 revenue $1,137M (+10% reported, +9% organic CC); adjusted EPS $0.19 vs $0.13 YoY (+46%).
- Adjusted EBITDA $198M (+21%); net leverage ratio improved to 3.7x from 4.3x at FY 2024 end.
- Raises FY 2025 revenue guidance to $4,645-4,670M and adjusted EPS to $0.91-0.94 (from $0.85-0.91).
- Pet Health revenue $533M (+10%), driven by Credelio Quattro ($100M net sales in <8 months) and Zenrelia.
- Refinanced $2.1B Term Loan B, extending maturities through 2032 and reducing interest cost.

## SEC filing metadata
- accession: 0001739104-25-000068
- form_type: 8-K
- ticker: ELAN
- cik: 0001739104
- company_name: Elanco Animal Health Inc
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739104/000173910425000068/0001739104-25-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739104/000173910425000068/elan-20251105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001739104-25-000068
- JSON: https://secwatch.observer/filing/0001739104-25-000068.json
- Plain text: https://secwatch.observer/filing/0001739104-25-000068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.